The development of nanomedicine is continuing with increasing pace. Nearly on a day-to-day basis new groundbreaking results from basic research are reported. More and more nanomedical concepts are entering into the phase of clinical studies, and the first nanotechnology-based medical products have been approved by the regulatory authorities.
In December 2010, experts from all over the world will gather for the 7th NanoMed conference in Berlin to discuss the state of the art in biomedical applications of nanotechnology. The NanoMed conference series started in 1999 and has since developed into one of the international lead events in this field. It is jointly organized by cc-NanoChem e. V. and NanoBioNet e. V., the two leading German networks in Chemical Nanotechnology and NanoBioTechnology.
The NanoMed Focus Topic 2010 will be „Nanotechnology-Enabled Diagnosis and Treatment of Cancer”. Every day, the world over, 20,000 people die from cancer. Therefore, understanding the mechanisms of this ailment, and developing novel diagnostic tools and therapeutic approaches is one of the main challenges for modern medical basic research. Nanotechnology can provide a wide range of new weapons against this fatal enemy: a new generation of specific biosensors, innovative imaging techniques, tumor treatment by hyperthermia, targeted nanoparticle-based drug and gene delivery to tumor sites, and photothermy, to name a few. About a third of the lectures and contributions of the NanoMed 2010 will be dedicated to this subject.
Beyond the Focus Topic, the scope of the conference covers the entire range of medical applications of nanotechnology, including, among others, drug delivery, drug targeting and controlled release, innovative dental materials, nanobioanalytics and diagnostic techniques based thereupon, nanomaterials for implants and regenerative medicine; microbicidal coatings for general hygiene and drug packaging, novel contrast agents, miniaturization of biochips, and bio-labelling with quantum dots.
The rise of nanotechnology has triggered a vivid debate on its potential risks for human health. Numerous research projects are addressing this topic. The NanoMed 2010 will provide a platform for the presentation of recent results in this field and for a discussion on this issue in the context of medical applications of nanomaterials.
Strong emphasis will be put on issues like intellectual property, financing of nanotechnology enterprises, regulatory affairs, clinical studies, technology transfer, and strategic collaboration between academic research, R&D companies and the pharmaceutical industry.
Dr. Karsten Moh | idw
Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"
13.04.2018 | Max-Planck-Institut für molekulare Genetik
Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018
12.04.2018 | Forschungsverbund Berlin e.V.
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy